Original InvestigationEditorial CommentBeta-Blockers in the Critically Ill: Friend or Foe?∗
Editorial Comment
Under an Elsevier user license
open archive
Corresponding Author
Key Words
acute care
ARDS
COVID
metoprolol
Cited by (0)
Christie Ballantyne, MD, served as the Guest Editor for this paper.
The author attests they are in compliance with human studies committees and animal welfare regulations of the author’s institution and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the Author Center.
- ∗
Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.
© 2021 by the American College of Cardiology Foundation. Published by Elsevier.